Tralitin Combi Tablet 2.5/500 mg
Linagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
MFDS item code 201904184 · Approved 2019.06.14
This product's status changed to Expired on 2024.06.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Initially, it can be administered if blood sugar control is difficult with monotherapy and no diabetes medication has been used. It can be used to replace combined therapy of linagliptin and metformin, and in cases where blood sugar control is insufficient with combined insulin and metformin therapy, it is administered in combination with insulin. Additionally, it is used to improve blood sugar control when blood sugar management is difficult even with the maximum dosage of metformin and empagliflozin by combining this medication with empagliflozin.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This medicine should be administered twice daily with meals. To reduce gastrointestinal adverse reactions associated with metformin use, the dose should be increased gradually. 1. Patients not currently receiving metformin: For patients with no prior history of antidiabetic drug treatment whose blood glucose is not adequately controlled with monotherapy, the initial dose is 1 tablet of this medicine 2.5/500 mg twice daily. The dose may be increased to 1 tablet of this medicine 2.5/1000 mg twice daily. 2. Switching from combination therapy with linagliptin and metformin: Patients switching from combination therapy with linagliptin and metformin to this medicine should take as the initial dose the same doses of linagliptin and metformin they were previously taking. 3. Patients whose blood glucose is not adequately controlled with combination therapy with insulin and metformin: The initial dose of this medicine should be considered to provide linagliptin 2.5 mg twice daily (total daily dose of 5 mg) and a dose similar to the patient's previous metformin dose. When this medicine is administered in combination with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 2. Administration with Caution in the Following Patients). No studies have been conducted to evaluate the safety and efficacy of switching to this medicine in patients previously treated with another oral blood glucose-lowering agent. Any change in the treatment regimen for type 2 diabetes may cause changes in blood glucose control; caution should be exercised and appropriate monitoring should be performed. Patients with renal impairment In patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate [eGFR] 45≤~<60 mL/min/1.73 m2), who do not have other conditions that may increase the risk of lactic acidosis, this medicine may be used with the following dose adjustments. Treatment should not be initiated with this medicine, because the starting dose of metformin is 500mg or 850mg once daily. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine must be discontinued immediately. Patients with hepatic impairment This medicine should not be administered to patients with hepatic impairment because it contains metformin (see Precautions for Use, 1. Do Not Administer to the Following Patients).
This medication helps to control blood sugar. However, it should not be used in patients with severely impaired kidney function or acute heart disease, or in patients with liver dysfunction. Pregnant or nursing women are also advised not to take this medication. This medication can cause hypoglycemia, so caution should be exercised to monitor blood sugar changes when used in combination with insulin or sulfonylureas. Particularly, the risk of hypoglycemia increases with excessive exercise, insufficient food intake, or alcohol consumption. A rare side effect known as lactic acidosis may occur, which poses a greater risk during sudden deterioration of kidney function, severe infections, or dehydration. In such cases, immediate consultation with a physician and cessation of medication are necessary. Regular blood tests to check kidney function and vitamin B12 levels are important during the use of this medication. Additionally, this medication may cause pancreatitis or blistering skin conditions, so any severe abdominal pain or skin abnormality symptoms should be reported to healthcare professionals immediately. There may be drug interactions; hence, if taking other medications, it is essential to inform the physician or pharmacist, especially when used with medications that affect the kidneys. The safety and efficacy of this medication have not been established in children, and dosage adjustments should be considered for elderly patients due to decreased kidney function. Finally, this medication should be stored out of the reach of children and protected from moisture.
Lactic acidosis, pharyngitis, hypersensitivity, angioedema, urticaria, decrease and deficiency of vitamin B12, hypoglycemia, taste disturbance, cough, decreased appetite, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, mouth ulcer formation, abnormal liver function tests, hepatitis, pruritus, erythema, rash, bullous pemphigoid, severe and disabling arthralgia, rhabdomyolysis, increased lipase, increased amylase, constipation, upper abdominal pain, small intestine and colitis, intestinal obstruction, gastroenteritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, stuttering, Alzheimer's type dementia, chest pain, fever, facial edema, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot syndrome, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscal injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anxiety, affective disorder, insomnia, depression, contusions, bone contusions, concussion, bone fractures, hand fractures, palpitations, dry eye, glaucoma, cataract, eye discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, thyroid enlargement, anemia, itching, hypertension, benign prostatic hyperplasia, angina, acute myocardial infarction, unstable angina, stomatitis, mediastinitis, vitreous hemorrhage, fever, ligament sprain, flank pain, myelodysplastic syndrome, vocal cord polyp, dyspepsia, anal bleeding, cheilitis, dental caries, enteritis, stomatitis, dizziness, drowsiness, chest discomfort, weakness, pain, epistaxis, oropharyngeal pain, voice disorder, nasal bleeding, wet cough, runny nose, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased serum triglycerides, increased urinary albumin/creatinine ratio, positive urinary leukocytes, decreased hemoglobin, increased serum potassium, increased serum creatinine, increased serum creatine kinase, increased ALT, male pattern baldness, hyperhidrosis, hair loss, dermatitis, anxiety, confusion, nocturia, dermatitis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the effectiveness of the medication and prevent degradation.
Bright yellow, biconvex, oval-shaped film-coated tablet
60 tablets (10 tablets/ PTP X 6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.